Abstract
Bioactivity-directed fractionation of the CHCl3 extract of the bark of Erythrina burana afforded phaseollidin [1] and cristacarpin [2]. Both 1 and 2 exhibited moderate but selective activity towards DNA repair-deficient yeast mutants, whereas only 1 was found to be cytotoxic. 13C-nmr spectra of both compounds were assigned.
Original language | English (US) |
---|---|
Pages (from-to) | 1831-1834 |
Number of pages | 4 |
Journal | Journal Of Natural Products |
Volume | 56 |
Issue number | 10 |
DOIs | |
State | Published - Oct 1993 |
Externally published | Yes |
ASJC Scopus subject areas
- Analytical Chemistry
- Molecular Medicine
- Pharmacology
- Pharmaceutical Science
- Drug Discovery
- Complementary and alternative medicine
- Organic Chemistry